Published in Blood Weekly, November 23rd, 2000
"Retrovirus-mediated gene transfer has been shown to transduce CD34+ cells from term gestation umbilical cord blood with relatively high efficiency," wrote L.E. Shields and colleagues, University of Washington. "The purpose of this study was to compare the efficiencies of retrovirus-mediated gene transfer into early (23-28 weeks' gestation) and term (37-41 weeks' gestation) umbilical cord blood CD34+ hematopoietic progenitor cells."
Shields et al. published their study in the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.